Dyne Therapeutics, Inc.DYNNASDAQ
Loading
Current Ratio Over TimeElevated
Percentile Rank93
3Y CAGR+33.0%
5Y CAGR-6.9%
Studio
Year-over-Year Change

Current ratio (current assets / current liabilities)

3Y CAGR
+33.0%/yr
vs -4.7%/yr prior
5Y CAGR
-6.9%/yr
Recent acceleration
Acceleration
+37.7pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
0.7x
Contraction
Streak
2 yr
Consecutive growthElevated
PeriodValueYoY Change
202522.25+42.6%
202415.60+516.2%
20232.53-73.2%
20229.46-29.0%
202113.31-58.2%
202031.83+408.5%
20196.26-45.4%
201811.47+689.8%
20171.45-55.4%
20163.26-